Modeling of Dysferlinopathy (LGMDR2) ProgressionCarla Bolano-Diaz, Chiara Calore, Harmen Reyngoudt et al.|Neurology Genetics|2025Cited by 3
Recommendations for the use of clinical outcome assessments in rare disease drug developmentOlalekan Lee Aiyegbusi, Steven Blackburn, Samantha Cruz Rivera et al.|EClinicalMedicine|2026Cited by 0